Abiraterone and enzalutamide had different adverse effects on the cardiovascular system: a systematic review with pairwise and network meta-analyses.

Hsiang Ying LeeHsiao-Ling ChenJeremy Yuen Chun TeohTun-Chieh ChenShao-Yuan HaoHsin-Yi TsaiWei-Hsuan HuangYung-Shun JuanHao-Min ChengHsiu-Mei Chang

Published in: Prostate cancer and prostatic diseases (2020)

Abiraterone and enzalutamide had different adverse effects on the cardiovascular system. We should take this into consideration when we are deciding on the choice of novel hormonal agents for patients with CRPC.

Keyphrases

meta analyses
prostate cancer
systematic review
randomized controlled trial
adverse drug
emergency department
polycystic ovary syndrome
type diabetes
skeletal muscle